Gait and Cognition in Parkinson’s Disease: Cognitive Impairment Is Inadequately Reflected by Gait Performance during Dual Task

Heiko Gaßner, Franz Marxreiter, Simon Steib, Zacharias Kohl, Johannes C. M. Schlachetzki, Werner Adler, Bjoern M. Eskofier, Klaus Pfeifer, Jürgen Winkler, Jochen KluckenFrontiers in Neurology 2017 · DOI

Abstract

These findings suggest that dual-task (DT) gait performance is not indicative of cognitive impairment in Parkinson’s Disease (PD). DT effects on gait parameters were substantial in both cognitively impaired and unimpaired patients, potentially overlaying the effect of cognitive impairment on DT gait costs. Limits of the Montreal Cognitive Assessment (MoCA) in detecting motor-function specific cognitive performance or variable individual response to the DT as influencing factors cannot be excluded. Therefore, DT gait parameters as a marker for cognitive performance should be carefully interpreted in the clinical context.

Introduction

A common clinical assumption in Parkinson’s Disease (PD) management is that significant gait degradation during a simultaneous mental task—a "dual-task" (DT) paradigm—serves as a clear indicator of cognitive impairment. This theory posits that gait changes reflect a lack of cognitive "reserve." However, whether these changes can serve as a reliable biomarker for cognitive decline remains debated. This study evaluates whether spatiotemporal gait parameters under DT conditions accurately reflect cognitive status as measured by the Montreal Cognitive Assessment (MoCA).

Methods

The researchers conducted a retrospective analysis of 67 PD patients selected from a larger cohort at the Movement Disorders Outpatient Clinic, University Hospital Erlangen.

Study flowchart illustrating patient selection, grouping by MoCA scores, and the experimental protocol.

Patients were categorized into "cognitively impaired" (MoCA < 26) and "unimpaired" (MoCA ≥ 26) groups, matched for age, gender, and disease duration. Gait analysis was performed using SHIMMER 2 inertial sensors on the heels to measure 13 spatiotemporal parameters. The protocol included:

  1. Single Task (ST): Walking 20 meters at a self-chosen speed.
  2. Dual Task (DT): Walking while performing serial subtractions of 3 from a random number.

The primary metric was "DT cost," defined as the percentage change in gait performance from ST to DT.

Results

The study revealed that DT gait performance is a poor predictor of clinical cognitive scores.

Correlation analysis between MoCA scores and the dual-task (DT) costs of various gait parameters, showing generally weak and non-significant relationships.

The "Cognitive Tank" Paradox

Surprisingly, both groups were significantly challenged by the dual task. The "unimpaired" group actually showed slightly larger DT costs in velocity and stride time, possibly due to prioritizing the cognitive task over walking.

Weak Predictive Power

Linear regression showed that DT gait parameters (specifically stride length, swing time variability, and max toe clearance) explained only 8.6% of the variance in MoCA scores. Even when accounting for clinical confounders like age and disease duration, the model's explanatory power only reached approximately 30%.

Universal Interference

Gait degradation was universal; velocity dropped by 24% in the impaired group and 32% in the unimpaired group. The interference between motor and cognitive tasks appears to be a general feature of PD that manifests independently of the clinical threshold for cognitive impairment.

Discussion

The findings suggest that while DT gait analysis is valuable for assessing fall risk and general motor-cognitive interference, it should not be used as a standalone diagnostic tool for cognitive impairment.

Several factors may contribute to this lack of correlation. The MoCA is a global screening tool and may not capture the specific executive functions, such as set-shifting or divided attention, required for dual-tasking. Additionally, the lack of explicit instructions regarding task prioritization (e.g., "posture-first") may have introduced individual variability. Finally, the difference in difficulty between the MoCA's "serial 7" task and the study's "serial 3" task might have masked potential correlations.

Clinicians should interpret DT gait parameters carefully within the broader clinical context rather than as a direct proxy for cognitive status.

Summary updated

Abstract

These findings suggest that DT gait performance is not indicative for cognitive impairment in PD. DT effects on gait parameters were substantial in cognitively impaired and unimpaired patients, thereby potentially overlaying the effect of cognitive impairment on DT gait costs. Limits of the MoCA in detecting motor-function specific cognitive performance or variable individual response to the DT as influencing factors cannot be excluded. Therefore, DT gait parameters as marker for cognitive performance should be carefully interpreted in the clinical context.
BibTeX
@inproceedings{ganer2017gait,
  author = {Heiko Gaßner and Franz Marxreiter and Simon Steib and Zacharias Kohl and Johannes C. M. Schlachetzki and Werner Adler and Bjoern M. Eskofier and Klaus Pfeifer and Jürgen Winkler and Jochen Klucken},
  title = {{Gait and Cognition in Parkinson’s Disease: Cognitive Impairment Is Inadequately Reflected by Gait Performance during Dual Task}},
  booktitle = {Frontiers in Neurology},
  year = {2017},
  doi = {10.3389/fneur.2017.00550},
}
Figure